ÂÜÀòÂÒÂ×

Robert Moreau is an experienced medicinal chemist with a strong academic background and extensive industry experience. Currently serving as Director at Mirador Therapeutics since June 2024, Robert previously held director and associate director roles at Interline Therapeutics from May 2021 to June 2024. Prior to that, Robert worked at the Novartis Institutes for BioMedical Research (NIBR) from July 2013 to May 2021, progressing through various investigator titles. Robert's career began at GNF as a Research Investigator I from March 2009 to June 2013. Educationally, Robert earned a PhD in Synthetic Organic Chemistry from Princeton University, following a position as a PhD candidate at Scripps Research, and holds an AB in Chemistry from the College of the Holy Cross.